ANTIBIOTIC RESISTANCE OF SHIGELLA AT THE PRESENT STAGE
Introduction. One of the major problems of practical public health at the present stage is the growth of Shigella's high antibiotic resistance to those antibacterial drugs that are widely used today in their treatment.
Objective: to study the sensitivity of the Shigella spp. strains isolated from the intestines of patients with acute dysentery to antimicrobials widely used in clinical practice.
Materials and methods.
A retrospective analysis of 236 medical records of patients with a diagnosis of acute dysentery treated on the basis of the Astana City Infectious Diseases Hospital for the period 2014-2016 was carried out. The sensitivity of Shigella to antibacterial drugs was determined in accordance with the guidelines of the Clinical Laboratory Standards Institute (CLSI, 2010) [9]. The degree of intestinal dysbiosis was determined in accordance with the classification of NM Gracheva and others [1, 3]. Statistic analysis of getting information was carried with SPSS program 12.0.2 for Windows.
Results. At the present stage, Sh.flexneri 2а, 2в, 1в, Shigella Sonnei 2е and 2d dominate in the etiological structure of shigellosis. Doxycycline, trimethoprim, ampicillin, tetracyclines, gentamicin and chloramphenicol cannot be used as starting therapy for shigellosis because of the fairly high level of resistance to them for shigella that has developed in recent years. In addition, currently there is a tendency to develop resistance of shigella to fluoroquinolone drugs (ciprofloxacin) and cephalosporins (cefotaxime, ceftriaxone), which are widely used in the treatment of this disease. In patients with shigellosis, subcompensated and decompensated disorders in the intestinal microflora are observed, which are aggravated under the influence of antibacterial drugs.
Conclusion: The development of a tendency to develop resistance of shigellosis pathogens to ciprofloxacin and cephalosporins (ceftriaxone, cefotaxime) at the present stage requires the supervision of the resistance of shigella to these antibiotics, which will serve as a basis for taking timely measures for antimicrobial therapy, rational choice of antimicrobial therapy.
Sholpan A. Kulzhanova 1, https://orcid.org/0000-0002-4118-4905
Gulsimzhan O. Turebaeva 1, https://orcid.org/0000-0001-8777-4874
1 Department of infectious diseases, JSC Astana Medical University,
Astana, Republic of Kazakhstan
1. Бондаренко В.М., Грачева Н.М., Мацулевич Т.В. Дисбактериозы кишечника у взрослых. - М., 2003. 224с.
2. Галушко Н.А., Дьяченко А.Г., Чемич Н.Д., Дьяченко П.А. Антибиотикорезистентность шигелл и рациональная этиотропная терапия шигеллезов // Журнал микробиологии, эпидемиологии и иммунобиологии. 2005. N 2. С.71-75.
3. Грачева Н.М., Ющук Н.Д., Чупринина Р.П. Дисбактериозы кишечника, причины возникновения, диагностика, применение бактерийных биологических препаратов. Пособие для врачей и студентов. – М., 1999. – 44с.
4. Малеев В.В., Иванов А.С., Страчунский Л.С. Резистентность шигелл и современные возможности антибактериальной терапии шигеллезов // Клиническая микробиология и антимикробная химиотерапия. 2005. Том 7. №4. С. 350-368.
5. Намазова-Баранова Л.С., Баранов А.А. Антибиотикорезистентность в современном мире// Педиатрическая фармакология. 2017. Том 14. №5. С. 341-354.
6. Халиуллина С.В., Леонтьева Н.С. Антибиотикорезистентность копроштаммов шигелл и сальмонелл, выделенных от детей, больных ОКИ. // Практическая медицина. 2010. №'7 (46). C. 137.
7. Черепахина И.Я., Балахнова В.В., Бурлакова О.С. и др. Мониторинг антибиотикорезистентности энтеробактерий, проводимый в рамках программы противодействия биотерроризму // Успехи современного естествознания. 2007. № 2. С. 31-35.
8. Черноземова Е.А., Дьячков А.Г. Видовая характеристика шигелл и их антибиотикорезистентность у больных дизентерией по данным КИБ им. С.П. Боткина//Инфекция и иммуните. 2014. №1. С. 97.
9. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing // Twentieth informational supplement document. 2010. Vol. 30, No 1. P. 108-114.
10. De Lappe N., O'Connor J., Garvey P., McKeown P., Cormican M. Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to India. Emerg Infect Dis. 2015. Vol. 21, No 5. P. 894-6.
11. Gaudreau C., Barkati S., Leduc J.M., Pilon P.A., Favreau J., Bekal S. Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013. Emerg Infect Dis. 2014. Vol. 20, No 5. P. 854-6.
12. Gaudreau C., Ratnayake R., Pilon P.A., Gagnon S., Roger M., Levesque S. Ciprofloxacin-resistant Shigellasonnei among men who have sex with men, Canada, 2010. Emerg Infect Dis. 2011. Vol. 17(9). P. 1747-50.
13. Laxminarayan R. et al. Antibiotic resistance-the need for global solutions // Lancet Infect Dis. 2013. Vol. 13(12). P. 1057–98.
14. Pons M.J., Gomes C., Martinez-Puchol S., Ruiz L., Mensa L., Vila J., Gascon J., Ruiz J. Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995-2010): a retrospective analysis // Travel Med Infect Dis. 2013. Vol. 11, No 5. P. 315-9.
15. Vk D., Srikumar S., Shetty S., Nguyen S., Karunasagar I., Fanning Silent S. Antibiotic resistance genes: A threat to antimicrobial therapy // International Journal of Infectious Diseases. 2019. Vol. 79, No1. P.20.
References:
1. Bondarenko V.M., Gracheva N.M., Maculevich T.V. Disbakteriozy kishechnika u vzroslykh [Intestinal dysbiosis in adults]. - M., 2003.- 224p. [in Russian]
2. Galushko N.A., D'jachenko A.G., Chemich N.D., D'jachenko P.A. Antibiotikorezistentnost' shigell i ratsional'naya etiotropnaya terapiya shigellezov [Antibiotic resistance of Shigella and rational etiotropic therapy of shigellosis]. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2005. No 2. pp.71-75. [in Russian]
3. Gracheva N.M., Jushhuk N.D., Chuprinina R.P. Disbakteriozy kishechnika, prichiny vozniknoveniya, diagnostika, primenenie bakteriinykh biologicheskikh preparatov. Posobie dlya vrachei i studentov. [Intestinal dysbiosis, causes, diagnosis, use of bacterial biological preparations. Handbook for doctors and students]. – M., 1999. – 44p. [in Russian]
4. Maleev V.V., Ivanov A.S., Strachunskii L.S. Rezistentnost' shigell i sovremennye vozmozhnosti antibakterial'noi terapii shigellezov [Resistance of Shigella and modern possibilities of antibacterial therapy of shigellosis]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya [Clinical microbiology and antimicrobial chemotherapy]. 2005.Vol 7. No 4. pp. 350-368. [in Russian]
5. Namazova-Baranova L.S., Baranov A.A. Antibiotikorezistentnost' v sovremennom mire [Antibiotic resistance in the modern world]. Pediatricheskaya farmakologiya [Pediatric Pharmacology]. 2017. Vol 14. No5. pp. 341-354. [in Russian]
6. Haliullina S.V., Leont'eva N.S. Antibiotikorezistentnost' koproshtammov shigell i sal'monell, vydelennykh ot detei, bol'nykh OKI [Antibiotic resistance of Shigella and Salmonella coproshtams isolated from children with acute intestinal infections]. Prakticheskaya meditsina [Practical medicine]. 2010. No7 (46). pp. 137. [in Russian]
7. Cherepahina I.Ya., Balahnova V.V., Burlakova O.S. i dr. Monitoring antibiotikorezistentnosti enterobakterii, provodimyi v ramkakh programmy protivodeistviya bioterrorizmu [Monitoring of antibiotic resistance of enterobacteria carried out as part of a program to counter bioterrorism]. Uspekhi sovremennogo estestvoznaniya [Advances in modern natural science.]. 2007. No 2. pp. 31-35. [in Russian]
8. Chernozemova E.A., D'yachkov A.G. Vidovaya kharakteristika shigell i ikh antibiotikorezistentnost' u bol'nykh dizenteriei po dannym infektsionnoi bol'nitsy im. S.P. Botkin [Species characteristic of Shigella and their antibiotic resistance in patients with dysentery according to the data of the Infectious Diseases Hospital S.P. Botkin,s named]. Infektsciya i immunitet [Infection and Immunity]. 2014. No 1. pp. 97. [in Russian]
9. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement document. – 2010. Vol. 30, No 1. 108-114.
10. De Lappe N., O'Connor J., Garvey P., McKeown P., Cormican M. Ciprofloxacin-Resistant Shigella sonnei Associated with Travel to India. Emerg Infect Dis. 2015. Vol. 21, No 5. P. 894-6.
11. Gaudreau C., Barkati S., Leduc J.M., Pilon P.A., Favreau J., Bekal S. Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012-2013. Emerg Infect Dis. 2014. Vol. 20, No 5. P. 854-6.
12. Gaudreau C., Ratnayake R., Pilon P.A., Gagnon S., Roger M., Levesque S. Ciprofloxacin-resistant Shigellasonnei among men who have sex with men, Canada, 2010. Emerg Infect Dis. 2011. Vol. 17(9). P. 1747-50.
13. Laxminarayan R., et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 013. Vol. 13(12). P. 1057–98.
14. Pons M.J., Gomes C., Martinez-Puchol S., Ruiz L., Mensa L., Vila J., Gascon J., Ruiz J. Antimicrobial resistance in Shigella spp. causing traveller's diarrhoea (1995-2010): a retrospective analysis. Travel Med Infect Dis. 2013. Vol. 11, No 5. P. 315-9.
15. Vk D., Srikumar S., Shetty S., Nguyen S., Karunasagar I., Fanning Silent S. Antibiotic resistance genes: A threat to antimicrobial therapy. International Journal of Infectious Diseases. 2019. Vol. 79, No1. P.20.
Number of Views: 271
Category of articles:
Original articles
Bibliography link
Кулжанова Ш.А., Туребаева Г.О. Антибиотикорезистентность шигелл на современном этапе // Наука и Здравоохранение. 2019. 1 (Т.21).С. 74-79. Kulzhanova Sh.A., Turebaeva G.O. Antibiotic resistance of shigella at the present stage // Nauka i Zdravookhranenie [Science & Healthcare]. 2019, (Vol.21) 1, pp. 74-79. Кулжанова Ш.А., Туребаева Г.О. Қазіргі сатыдағы шигеллалардың антибиотиктерге төзімділігі // Ғылым және Денсаулық сақтау. 2019. 1 (Т.21). Б. 74-79.Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS